Clinical Trial Update: Safety, Efficacy and Pharmacokinetic Characteristics of KR230109 Cream in Facial Acne Vulgaris [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety, efficacy, and pharmacokinetics of KR230109 Cream for facial acne vulgaris. The study is currently NOT_YET_RECRUI…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• KR230109 Cream

Snippet

Sponsor: Jiangxi Kvvit Pharmaceutical Co., Ltd. | Conditions: Acne Vulgaris | Phase 2 | Status: NOT_YET_RECRUITING